Silence Therapeutics plc
SLN—
Silence Therapeutics plcSLN$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-0.63
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$559,000
Net income
$-88.61M
Net margin
-15851.9%
Gross margin
61.5%
Dividends & financials
Silence Therapeutics plc (SLN) reported revenue of $559,000 and net income of $-88.61M, or $-0.63 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.